Sag L News Today

Shore Capital restated their house stock rating on shares of AG.L (LON:AG – Free Report) in a report released on Tuesday, LSE.Co.UK reports. AG.L Stock Performance About AG.L (Get Free Report) First Majestic is a publicly traded mining company focused on silver production in Mexico and is aggressively pursuing the development of its existing mineral […]

Peel Hunt reissued their buy rating on shares of AG.L (LON:AG – Free Report) in a research report released on Tuesday, LSE.Co.UK reports. Peel Hunt currently has a GBX 600 ($7.33) target price on the stock. Separately, Shore Capital reiterated a house stock rating on shares of AG.L in a research report on Tuesday. Check […]

Liberum Capital reissued their buy rating on shares of AG.L (LON:AG – Free Report) in a research note released on Tuesday morning, LSE.Co.UK reports. Liberum Capital currently has a GBX 600 ($7.33) price target on the stock. Several other brokerages have also issued reports on AG. Peel Hunt reiterated a buy rating and issued a […]

Peel Hunt reaffirmed their buy rating on shares of AG.L (LON:AG – Get Rating) in a research note published on Tuesday morning, LSE.Co.UK reports. Peel Hunt currently has a GBX 595 ($7.75) price objective on the stock. Several other brokerages have also recently issued reports on AG. Berenberg Bank raised shares of AG.L to a […]

Berenberg Bank upgraded shares of AG.L (LON:AG – Get Rating) to a buy rating in a research report report published on Friday, LSE.Co.UK reports. The brokerage currently has GBX 660 ($8.60) price target on the stock, up from their prior price target of GBX 580 ($7.56). Several other analysts also recently weighed in on AG. […]

28 May 2021 | 12:02pm StockMarketWire.com - The FTSE 100 was 0.35% higher at 7,044.36 as investors awaited details of president Bidens potential $6 trillion budget later. Pharma giant AstraZeneca said Tagrisso had been approved in the European Union to treat patients with early-stage epidermal growth factor receptor-mutated non-small cell lung cancer. The approval by the European Commission was based on positive results from the ADAURA phase 3 trial. AstraZenecas share price rose by 1.09% to £...

9 March 2021 | 08:57am StockMarketWire.com - Consultancy firm Science Group swung to a full-year profit that it said exceeded expectations after sales were boosted its acquisition of radio chip group Frontier Smart Technologies. Pre-tax profit for the year through December amounted to £6.4 million, compared to a year-on-year loss of £1.6 million, as revenue climbed 29% to £73.7 million. Adjusted operating profit jumped 62% to £10.9 million and the company declared a full-year dividend of 4p...